Curt LaBelle
InvestorManaging Partner at Global Health Investment Fund Β· Venture Partner at Adjuvant Capital
New York
About
Curt LaBelle is a Venture Partner at Adjuvant Capital with over 16 years of experience investing in healthcare companies. He was previously a managing director at Tullis Health Investors and a vice president at Investor Growth Capital. He holds a BS in economics from Brigham Young University and both MD and MBA degrees from Columbia University.
Invests in
BiotechDigital HealthHealthtechMedical Devices
Experience
- AXA IM Global Health Private EquityManaging Partnercurrent2022 β present
- AXA IM Prime Impact FundAdvisorcurrent2020 β present
- Novocuff, Inc.Board Membercurrent2024 β presentUnited States
- Vedanta Biosciences, Inc.Board Membercurrent2023 β presentCambridge, Massachusetts, United States
- Epion TherapeuticsBoard Membercurrent2022 β presentGreater Boston
- Maternal Newborn Health InnovationsBoard Membercurrent2022 β present
- Ophirex, Inc.Board Membercurrent2022 β presentSan Francisco Bay Area
- Z OpticsChair Of The Board Of Directorscurrent2020 β presentUnited States
- Atticus MedicalMember, Board of Directorscurrent2015 β present
- Serum InstituteChair, Steering Committee2017 β 2023Pune, India
- Atomo Diagnostics (ASX: AT1)Member, Board Of Directors2016 β 2023
- Global Health Investment FundManaging Partner2015 β 2023Greater New York City Area
- IanTech (acquired by Zeiss)Lead Investor, Head of Global Access Committee2015 β 2023
- Revelation Biosciences Inc.Board Member2021 β 2023
- Eyenovia (Nasdaq EYEN)Board Member2015 β 2022
- Alydia Health (acquired by Organon)Chair, Board Of Directors2018 β 2021
- SafeOp Surgical (acquired by Alphatec)Chair Of The Board Of Directors2011 β 2015Stamford, CT
- Exagen Inc. (Nasdaq XGN)Chair, Board of Directors2009 β 2015
- Tullis Health InvestorsManaging Director2008 β 2015Stamford, CT
- Estech (acquired by Atricure)Board Observer2010 β 2013San Francisco Bay Area
Education
- Columbia Business SchoolMBA1998 β 1999
- Columbia University Vagelos College of Physicians and SurgeonsMD1994 β 1999
- Brigham Young UniversityBachelorβs Degree, Economics
Skills & more
Impact Investing1Venture FinancingGrowth CapitalOphthalmology
Languages English Β· Finnish
From Curt's professional profile.
Same school
Also attended Columbia Business School577
Aryo TehranianManaging Director at Mayfair Equity PartnersYibo NianInvestment Director at Intel CapitalKesha CashFounder & General Partner at Impact America FundMahati SridharPartner, Rise of the Rest at RevolutionGiuseppe IademarcoHead of Global Partnership at P101 VenturesWendy XiaoPartner at Northzone
+ 571 more
Also attended Columbia University Vagelos College of Physicians and Surgeons13
Deborah PalestrantPartner, Executive Chair, 4:59 Initiative at 5AM VenturesJoseph MayerPartner at HLM Investment PartnersJoan LaRovereOperating Partner at iSelect FundJonathan GertlerManaging Director at Bioventures InvestorsMyla Lai-GoldmanVenture Partner at Hatteras Venture PartnersBijan SalehizadehManaging Director at NaviMed Capital
+ 7 more
Also attended Brigham Young University194
Jake StormDeal Partner at Felicis VenturesJen ArdManaging Director, Head of Investment Operations at Intel CapitalNathan MickelsenVice President of Tax at RevolutionJohn SabinChief Financial Officer; President, Revolution Places at RevolutionDiogo MyrrhaPartner at Peak VenturesSid KrommenhoekPartner at Peak Ventures
+ 188 more
Shared employers
Also worked at Novocuff, Inc.1
Also worked at Tullis Health Investors5
Kathrine KowalikDirector of Investor Relations at WAVE Equity PartnersSteven GindiChief Financial Officer at Tullis Health InvestorsDavid LeffellVenture Partner, MD at Tullis Health InvestorsDarlene FranzΓ©Vice President, Administration at Tullis Health InvestorsMelanie OldemanVice President, Investor Communications at Tullis Health Investors
Investments
Board seats
CoherexEstechExagen DiagnosticsImpulse MonitoringKAI PharmaceuticalsSafeOpSirion TherapeuticsTransMolecular
Per the firm's website.














.avif)







